← back to search

Jesse Novak

Howard Hughes Medical Institute · US
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Microtubule and mitosis dynamics, Immunotherapy and Immune Responses, and Immune cells in cancer.
h-index
14
citations
4,070
works
79
NIH funding
primary concept
email

Recent publications

The integrated stress response fine-tunes stem cell fate decisions upon serine deprivation and tissue injury
Cell Metabolism 2025cited by 7position: firstdoi
Stem cells expand potency and alter tissue fitness by accumulating diverse epigenetic memories
Science 2021cited by 139position: middledoi
Extracellular serine controls epidermal stem cell fate and tumour initiation
Nature Cell Biology 2020cited by 122position: middledoi
Author Correction: Extracellular serine controls epidermal stem cell fate and tumour initiation
Nature Cell Biology 2020cited by 4position: middledoi
Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival
Cancer Discovery 2018cited by 176position: middledoi
Autochthonous tumors driven by <i>Rb1</i> loss have an ongoing requirement for the RBP2 histone demethylase
Proceedings of the National Academy of Sciences 2018cited by 16position: middledoi
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
Cancer Discovery 2017cited by 148position: middledoi
HIF activation causes synthetic lethality between the <i>VHL</i> tumor suppressor and the <i>EZH1</i> histone methyltransferase
Science Translational Medicine 2017cited by 46position: middledoi
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Genome biology 2016cited by 2,760position: middledoi
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
Science 2016cited by 208position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Elaine Fuchs · Howard Hughes Medical Institute4 papers (2020–2025)Sabina Signoretti · Cancer Research Center4 papers (2016–2018)William G. Kaelin · Harvard University3 papers (2016–2018)June dela Cruz-Racelis · Howard Hughes Medical Institute3 papers (2020–2025)Sanjeethan C. Baksh · Howard Hughes Medical Institute3 papers (2020–2025)Lydia W.S. Finley · Cornell University3 papers (2020–2025)Shiri Gur‐Cohen · Howard Hughes Medical Institute3 papers (2020–2025)Matthew Tierney · Discovery Institute3 papers (2020–2021)Yejing Ge · The University of Texas MD Anderson Cancer Center2 papers (2020–2020)Kevin Andrew Uy Gonzales · Genomics (United Kingdom)2 papers (2021–2025)Anita Gola · Rockefeller University2 papers (2021–2025)H. Amalia Pasolli · Rockefeller University2 papers (2021–2025)Brian Hurwitz · Howard Hughes Medical Institute2 papers (2020–2020)Lisa Polak · New York University2 papers (2021–2025)Samuel K. McBrayer · Dana-Farber Brigham Cancer Center2 papers (2017–2018)Abhishek A. Chakraborty · Case Western Reserve University2 papers (2016–2017)Pavlina Krasimirova Todorova · The University of Texas Southwestern Medical Center2 papers (2020–2020) · 1 papers (2025–2025)Pengda Liu · University of North Carolina at Chapel Hill1 papers (2016–2016)Jun Qi · Harvard University1 papers (2017–2017)